Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
amlodipine (norvasc) (2 trials)
atorvastatin (lipitor) (1 trial)
ckd-348 (2 trials)
ckd-386 (1 trial)
dapagliflozin (farxiga) (2 trials)
meloxicam (mobic) (1 trial)
nvp-1705 (1 trial)
nvp-2102 (1 trial)
olmesartan (benicar) (1 trial)
telmisartan (micardis) (2 trials)
tofacitinib (xeljanz) (1 trial)
Diabetes Mellitus, Type 2 (Phase 1)
Dyslipidemias (Phase 1)
Trials (10 total)
Trial APIs (11 total)